In vivo, mice injected with miR-429-transfected breast cancer cells had reduced cancer-induced osteolysis when compared to a control, and histological analysis of the bone metastases showed a reduction in both CrKL and MMP-9 expression in the miR-429 group [48]. The gene discussed is CRKL; the disease is breast carcinoma.